Publications by authors named "Jodi A Muscal"

Claim this Profile
P
Phase 1 trial of olaratumab monotherapy and in combination with chemotherapy in pediatric patients with relapsed/refractory solid and central nervous system tumors.
Leo Mascarenhas, Chitose Ogawa, Theodore W Laetsch, Brenda J Weigel, Michael W Bishop, Jodi A Muscal

Cancer Med· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevention of Recurrent Mucinous Borderline Ovarian Tumor with Aromatase Inhibitor.
Kathryn C Stambough, Jodi A Muscal, Creighton L Edwards, Jennifer E Dietrich

J Pediatr Adolesc Gynecol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BCOR-CCNB3 fusion-positive clear cell sarcoma of the kidney.
Hyojeong Han, Kelsey C Bertrand, Kalyani R Patel, Kevin E Fisher, Angshumoy Roy, Jodi A Muscal

Pediatr Blood Cancer· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Salvage sacrococcygeal resection for yolk sac tumors after chemotherapy: report of 2 cases.
Vijay M Ravindra, Lucia Ruggieri, Sanjeev A Vasudevan, M John Hicks, Jodi A Muscal

J Neurosurg Pediatr· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mentors' perspectives on the successes and challenges of mentoring in the COG Young Investigator mentorship program: A report from the Children's Oncology Group.
Adam J Esbenshade, Lisa S Kahalley, Reto Baertschiger, Roshni Dasgupta, Kelly C Goldsmith, Jodi A Muscal

Pediatr Blood Cancer· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concurrent Inhibition of Neurosphere and Monolayer Cells of Pediatric Glioblastoma by Aurora A Inhibitor MLN8237 Predicted Survival Extension in PDOX Models.
Mari Kogiso, Lin Qi, Frank K Braun, Sarah G Injac, Linna Zhang, Jodi A Muscal

Clin Cancer Res· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term evidence that a pediatric oncology mentorship program for young investigators is feasible and beneficial in the cooperative group setting: A report from the Children's Oncology Group.
Adam J Esbenshade, Christopher R Pierson, Amanda L Thompson, Damon Reed, Abha Gupta, Jodi A Muscal

Pediatr Blood Cancer· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Borderline Ovarian Tumor in the Pediatric and Adolescent Population: A Case Series and Literature Review.
Krista J Childress, Ninad Mohan Patil, Jodi A Muscal, Jennifer E Dietrich, Rajkumar Venkatramani

J Pediatr Adolesc Gynecol· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Small molecule inhibitor regorafenib inhibits RET signaling in neuroblastoma cells and effectively suppresses tumor growth .
Zhenghu Chen, Yanling Zhao, Yang Yu, Jonathan C Pang, Sarah E Woodfield, Jodi A Muscal

Oncotarget· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The second-generation ALK inhibitor alectinib effectively induces apoptosis in human neuroblastoma cells and inhibits tumor growth in a TH-MYCN transgenic neuroblastoma mouse model.
Jiaxiong Lu, Shan Guan, Yanling Zhao, Yang Yu, Sarah E Woodfield, Jodi A Muscal

Cancer Lett· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel Src/Abl tyrosine kinase inhibitor bosutinib suppresses neuroblastoma growth via inhibiting Src/Abl signaling.
Shayahati Bieerkehazhi, Zhenghu Chen, Yanling Zhao, Yang Yu, Huiyuan Zhang, Jodi A Muscal

Oncotarget· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Childhood and adolescent tracheobronchial mucoepidermoid carcinoma (MEC): a case-series and review of the literature.
Sergio Jaramillo, Yesenia Rojas, Bethany J Slater, Michael L Baker, M John Hicks, Jodi A Muscal

Pediatr Surg Int· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mucoepidermoid Carcinoma in Children: A Single Institutional Experience.
Piti Techavichit, M John Hicks, Dolores H López-Terrada, Norma M Quintanilla, R Paul Guillerman, Jodi A Muscal

Pediatr Blood Cancer· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel ALK inhibitor AZD3463 inhibits neuroblastoma growth by overcoming crizotinib resistance and inducing apoptosis.
Yongfeng Wang, Long Wang, Shan Guan, Wenming Cao, Hao Wang, Jodi A Muscal

Sci Rep· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1 evaluation of EZN-2208, a polyethylene glycol conjugate of SN38, in children adolescents and young adults with relapsed or refractory solid tumors.
Robin E Norris, Suzanne Shusterman, Lia Gore, Jodi A Muscal, Margaret E Macy

Pediatr Blood Cancer· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I trial of imetelstat in children with refractory or recurrent solid tumors: a Children's Oncology Group Phase I Consortium Study (ADVL1112).
Patrick A Thompson, Rachid Drissi, Jodi A Muscal, Eshini Panditharatna, Maryam Fouladi

Clin Cancer Res· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I trial of vorinostat and bortezomib in children with refractory or recurrent solid tumors: a Children's Oncology Group phase I consortium study (ADVL0916).
Jodi A Muscal, Patrick A Thompson, Terzah M Horton, Ashish M Ingle, Charlotte H Ahern

Pediatr Blood Cancer· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Additive effects of vorinostat and MLN8237 in pediatric leukemia, medulloblastoma, and neuroblastoma cell lines.
Jodi A Muscal, Kathleen A Scorsone, Linna Zhang, Jeffrey A Ecsedy, Stacey L Berg

Invest New Drugs· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma and cerebrospinal fluid pharmacokinetics of thalidomide and lenalidomide in nonhuman primates.
Jodi A Muscal, Yongkai Sun, Jed G Nuchtern, Robert C Dauser, Leticia H McGuffey

Cancer Chemother Pharmacol· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma and cerebrospinal fluid pharmacokinetics of ABT-888 after oral administration in non-human primates.
Jodi A Muscal, Patrick A Thompson, Vincent L Giranda, Brian D Dayton, Joy Bauch

Cancer Chemother Pharmacol· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes mimicking new leptomeningeal disease after intensity-modulated radiotherapy for medulloblastoma.
Jodi A Muscal, Jeremy Y Jones, Arnold C Paulino, Alison A Bertuch, Jack Su

Int J Radiat Oncol Biol Phys· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis